DK100982A - Fremgangsmaade til fremstilling af cephalosporinantibiotika - Google Patents

Fremgangsmaade til fremstilling af cephalosporinantibiotika Download PDF

Info

Publication number
DK100982A
DK100982A DK100982A DK100982A DK100982A DK 100982 A DK100982 A DK 100982A DK 100982 A DK100982 A DK 100982A DK 100982 A DK100982 A DK 100982A DK 100982 A DK100982 A DK 100982A
Authority
DK
Denmark
Prior art keywords
cephalosporin antibiotics
preparing cephalosporin
preparing
antibiotics
cephalosporin
Prior art date
Application number
DK100982A
Other languages
Danish (da)
English (en)
Inventor
W H W Lunn
J K Shadle
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK100982A publication Critical patent/DK100982A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK100982A 1981-03-11 1982-03-09 Fremgangsmaade til fremstilling af cephalosporinantibiotika DK100982A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/242,792 US4336253A (en) 1981-03-11 1981-03-11 Cephalosporin antibiotics

Publications (1)

Publication Number Publication Date
DK100982A true DK100982A (da) 1982-09-12

Family

ID=22916202

Family Applications (1)

Application Number Title Priority Date Filing Date
DK100982A DK100982A (da) 1981-03-11 1982-03-09 Fremgangsmaade til fremstilling af cephalosporinantibiotika

Country Status (21)

Country Link
US (1) US4336253A (ro)
EP (1) EP0060144A3 (ro)
JP (1) JPS57165393A (ro)
KR (1) KR830009119A (ro)
AU (1) AU8091182A (ro)
BG (1) BG36936A3 (ro)
CA (1) CA1177066A (ro)
CS (1) CS238620B2 (ro)
DD (1) DD201599A5 (ro)
DK (1) DK100982A (ro)
ES (1) ES510307A0 (ro)
FI (1) FI820806L (ro)
GB (1) GB2094309B (ro)
GR (1) GR74714B (ro)
IL (1) IL65185A0 (ro)
NZ (1) NZ199959A (ro)
PH (1) PH17022A (ro)
PL (1) PL130568B1 (ro)
PT (1) PT74558B (ro)
RO (1) RO82962B (ro)
ZA (1) ZA821525B (ro)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443444A (en) * 1980-08-11 1984-04-17 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
US4450270A (en) * 1981-10-02 1984-05-22 Eli Lilly And Company Dioximino cephalosporin antibiotics
US4616081A (en) * 1982-07-07 1986-10-07 Asahi Kasei Kogyo Kabushiki Kaisha Cephalosporin compounds
DE3316797A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
DE3316798A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
ATE121746T1 (de) * 1984-11-23 1995-05-15 Biochemie Gmbh Verfahren zur herstellung bissilylierter 3- iodmethylcephalosporinderivaten.
US4703118A (en) * 1985-04-08 1987-10-27 Eli Lilly And Company Synthesis of 3-iodomethyl cephalosporins
US4714760A (en) * 1985-08-20 1987-12-22 Bristol-Myers Company Cephalosporin intermediates
US4749522A (en) * 1985-10-31 1988-06-07 Angio-Medical Corporation Supercritical fluid extraction of animal derived materials
US4868294A (en) * 1986-07-11 1989-09-19 Bristol-Myers Company Process for preparing cephalosporin intermediates
PL1618114T3 (pl) 2003-04-16 2010-12-31 Sandoz Ag Sposoby otrzymywania cefepimy
US7847093B2 (en) * 2003-04-16 2010-12-07 Sandoz Ag Processes for the preparations of cefepime
WO2006008749A1 (en) * 2004-07-16 2006-01-26 Hetero Drugs Limited Process for preparing pure cephalosporine intermediates
EP2862569A1 (en) 2011-09-09 2015-04-22 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
KR102226197B1 (ko) 2013-03-15 2021-03-11 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792047A (en) * 1971-12-07 1974-02-12 Glaxo Lab Ltd N-(7,2'-thienylacetamidoceph-3-em-3-ylmethyl)-3"or 4"-n-hydroxyloweralkylcarbamoyl-pyridinium-4-carboxylates
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
JPS52125188A (en) 1976-04-14 1977-10-20 Takeda Chem Ind Ltd Cephalosporin derivatives and their preparation
GR63088B (en) * 1976-04-14 1979-08-09 Takeda Chemical Industries Ltd Preparation process of novel cephalosporins
JPS6011713B2 (ja) * 1976-09-08 1985-03-27 武田薬品工業株式会社 セフアロスポリン誘導体およびその製造法
GB2027692B (en) 1978-05-26 1983-02-09 Glaxo Group Ltd Cephalosporin antibiotics
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
JPS54154786A (en) 1978-05-26 1979-12-06 Glaxo Group Ltd Cephalosporin compound
FR2449692A1 (fr) 1979-02-23 1980-09-19 Glaxo Group Ltd Nouvelles cephalosporines qui exercent une activite contre les organismes gram-negatifs
US4237128A (en) * 1979-04-12 1980-12-02 E. R. Squibb & Sons, Inc. 7-[2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1,1-dialkyl)alkoxyimino]acetamido]cephem sulfoxides

Also Published As

Publication number Publication date
PT74558B (en) 1984-11-27
KR830009119A (ko) 1983-12-17
RO82962A (ro) 1984-01-14
IL65185A0 (en) 1982-05-31
EP0060144A2 (en) 1982-09-15
AU8091182A (en) 1982-09-16
ES8303426A1 (es) 1983-02-01
CA1177066A (en) 1984-10-30
BG36936A3 (en) 1985-02-15
JPS57165393A (en) 1982-10-12
DD201599A5 (de) 1983-07-27
PH17022A (en) 1984-05-11
GB2094309A (en) 1982-09-15
US4336253A (en) 1982-06-22
PL235396A1 (ro) 1982-09-27
PL130568B1 (en) 1984-08-31
ES510307A0 (es) 1983-02-01
ZA821525B (en) 1983-03-30
PT74558A (en) 1982-04-01
GR74714B (ro) 1984-07-06
EP0060144A3 (en) 1983-09-14
NZ199959A (en) 1985-08-16
CS238620B2 (en) 1985-12-16
FI820806L (fi) 1982-09-12
GB2094309B (en) 1985-03-27
RO82962B (ro) 1984-01-30

Similar Documents

Publication Publication Date Title
DK100982A (da) Fremgangsmaade til fremstilling af cephalosporinantibiotika
DK95383D0 (da) Fremgangsmade til fremstilling af cephalosporinderivater
DK343682A (da) Fremgangsmaade til fremstilling af thiazolidinylalkylen-piperazin-derivater
DK86283D0 (da) Fremgangsmade til fremstilling af cephalosporinderivater
DK416082A (da) Fremgangsmaade til fremstilling af aminopropanolderivater af 2-hydroxy-beta-phenylpropiophenoner
DK78580A (da) Fremgangsmaade til fremstilling af cephalosporinantibiotika
DK158983A (da) Fremgangsmaade til fremstilling af lankacidin-antibiotika
DK487979A (da) Fremgangsmaade til fremstilling af cephalosporinantibiotika
DK392082A (da) Fremgangsmaade til fremstilling af antibiotiket nosiheptid
NO822480L (no) Fremgangsmaate for fremstilling av et antibiotikum
DK165118C (da) Fremgangsmaade til fremstilling af oploesninger af 7-aminocephalosporansyrer
DK355584A (da) Fremgangsmaade til fremstilling af 3-exomethylen-cephalosporiner
DK343782A (da) Fremgangsmaade til fremstilling af spirothiazolidinyl-piperazin-derivater
DK501582A (da) Fremgangsmaade til fremstilling af acylcyanider
DK105082A (da) Fremgangsmaade til fremstilling af substituerede trifluormethylphenyl-tetrahydropyridiner
DK23784A (da) Fremgangsmaade til fremstilling af beta-lactam
DK457983A (da) Fremgangsmaade til fremstilling af beta-lactam
DK223583A (da) Fremgangsmaade til fremstilling af cephalosporinantibiotika
DK75582A (da) Fremgangsmaade til fremstilling af beta-lactam-antibiotika
ES526647A0 (es) Metodo de preparar derivados de p-acilaminofenol
DK76482A (da) Fremgangsmaade til fremstilling af antibiotikaene ll-b01208alfa og ll-b01208beta
DK412281A (da) Fremgangsmaade til fremstilling af bis-tetrazolmethyl-substituerede beta-lactam-antibiotika
DK298983A (da) Fremgangsmaade til fremstilling af cephalosporinantibiotika
DK212884D0 (da) Fremgangsmaade til fremstilling af isoxazolylimidazolidinoner
DK380484D0 (da) Fremgangsmaade til fremstilling af penicillin- og cephalosporinsulfoer

Legal Events

Date Code Title Description
ATS Application withdrawn